Skip to content

Adjustment of intraocular Pressure (IOP)-lowering medication for Normal Tension Glaucoma (NTG) suspects and pre-perimetric NTG

Adjustment of intraocular Pressure (IOP)-lowering medication for Normal Tension Glaucoma (NTG) suspects and pre-perimetric NTG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119285
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Tension Glaucoma (NTG) suspects and pre-perimetric NTG

Interventions

Single intervention group:Adjustment of IOP-lowering medication

Sponsors

Faculty of Medicine, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. BCVA >=20/40; 3. 360° gonioscopically open anterior chamber angles; 4. 6 median untreated IOP reading consistently 24 mmHg. At least 2 readings were obtained at a different time of the day from the rest (IOP measurement for eligibility assessment are obtained after washout of pre-study topical IOP-lowering medication for 4 weeks); 5. Three reliable VF results without VF defect; 6. PNTG: Fundus photography or OCT show glaucomatous changes: narrowed neuroretinal rim, optic disc cupping, presence of disc hemorrhage, RNFL defect, or GCIPL defect. RNFL defect is defined when (1) >=20 contiguous superpixels (1 superpixel = 4x4 pixels, instrument default) were encoded in red (i.e., RNFL thickness below 1st percentile) in the RNFL thickness deviation map, and (2) the abnormalities were also observed in the RNFL thickness map at the corresponding location); 7. NTG suspect: Patients without the above structural glaucomatous features but was diagnosed NTG. 8. One eye or both eyes of each patient could be recruited for the study.

Exclusion criteria

Exclusion criteria: 1. Patients unwilling to be monitored without treatment; 2. Second cause of glaucoma (e.g., previous trauma, steroid use, uveitis); 3. Ocular or systemic disease that may cause VF loss or optic disc abnormalities; 4. High myopia (spherical error <-10.0D); 5. history of glaucoma surgery, glaucoma laser procedure, or corneal refractive surgery; 6. Patients who had previous ocular surgery or laser procedure (except uncomplicated cataract surgery, laser capsulotomy, or retinal barrier laser); 7. Inability to perform reliable VF; 8. Suboptimal quality of OCT images; 9. VF defect that fulfills the minimal criterial of glaucomatous VF defect: glaucoma hemifield test result outside normal limits, pattern standard deviation with P<0.05 or a cluster of 3 or more points in the pattern deviation plot in a single hemifield (superior or inferior) with P<0.05 one of which must have P<0.01. Any one of the preceding criteria, if

Design outcomes

Secondary

MeasureTime frame
The number of patients that require resumption of medication.;

Primary

MeasureTime frame
The potential cost-saving that could be achieved with a systematic approach of adjusting medication for PNTG and NTG suspects.;

Countries

China

Contacts

Public ContactCHAN Pui Man Poemen

Department of Ophthalmology and Visual Sciences

poemenchan@cuhk.edu.hk+852 3943 5807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026